Two Sigma Investments’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$349K Sell
43,621
-3,130
-7% -$25K ﹤0.01% 2687
2025
Q1
$456K Buy
46,751
+24,193
+107% +$236K ﹤0.01% 2498
2024
Q4
$285K Sell
22,558
-42,495
-65% -$537K ﹤0.01% 2688
2024
Q3
$1.05M Sell
65,053
-11,485
-15% -$185K ﹤0.01% 2034
2024
Q2
$1.87M Buy
76,538
+23,338
+44% +$569K ﹤0.01% 1531
2024
Q1
$3.82M Buy
53,200
+49,120
+1,204% +$3.53M 0.01% 1064
2023
Q4
$811K Buy
4,080
+1,705
+72% +$339K ﹤0.01% 2121
2023
Q3
$316K Sell
2,375
-3,450
-59% -$459K ﹤0.01% 2398
2023
Q2
$871K Sell
5,825
-2,145
-27% -$321K ﹤0.01% 1945
2023
Q1
$1.17M Buy
7,970
+5,395
+210% +$792K ﹤0.01% 1713
2022
Q4
$408K Buy
+2,575
New +$408K ﹤0.01% 2055
2022
Q3
Sell
-1,475
Closed -$215K 2698
2022
Q2
$215K Sell
1,475
-8,374
-85% -$1.22M ﹤0.01% 2069
2022
Q1
$1.73M Sell
9,849
-7,341
-43% -$1.29M 0.01% 1390
2021
Q4
$5.05M Sell
17,190
-9,227
-35% -$2.71M 0.01% 905
2021
Q3
$6.56M Buy
26,417
+1,060
+4% +$263K 0.01% 770
2021
Q2
$6.45M Buy
25,357
+21,219
+513% +$5.4M 0.01% 809
2021
Q1
$735K Sell
4,138
-1,350
-25% -$240K ﹤0.01% 1718
2020
Q4
$867K Buy
5,488
+3,808
+227% +$602K ﹤0.01% 1402
2020
Q3
$433K Buy
+1,680
New +$433K ﹤0.01% 1469